AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RenovoRx, Inc. Director's Dealing 2021

Aug 25, 2021

34656_dirs_2021-08-25_844d1ad2-e5e7-4289-8a7d-690e17e3e9ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RenovoRx, Inc. (RNXT)
CIK: 0001574094
Period of Report: 2021-08-25

Reporting Person: Marton Laurence (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Ownership
Stock Option (right to buy)	$0.65	2028-07-10	Common Stock (32000)	Direct
Stock Option (right to buy)	$0.15	2025-10-14	Common Stock (20480)	Direct
Stock Option (right to buy)	$0.10	2023-04-02	Common Stock (25438)	Direct

Footnotes

F1: 1/48th of the shares subject to the option began vesting monthly on January 1, 2018, and the remaining unvested shares will continue to vest according to the same schedule until fully vested on January 1, 2022.

F2: The shares subject to the option are fully vested.

F3: The shares subject to the option are fully vested.